Anzeige
Meldung des Tages: Diese Zahlen lügen nicht: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Apellis Pharmaceuticals News

Aktie
WKN:  A2JAAW ISIN:  US03753U1060 US-Symbol:  APLS Branche:  Biotechnologie Land:  USA
34,65 €
-0,05 €
-0,14%
17.04.26
Depot/Watchlist
Marktkapitalisierung *
2,64 Mrd. €
Streubesitz
-
KGV
91,36
Nachhaltigkeits-Score
22 %
Index-Zuordnung
-

Apellis Pharmaceuticals News

14.04.26 - PR Newswire
Are GSAT, APLS, FORA Obtaining Fair Deals for their Shareholders?
Are GSAT, APLS, FORA Obtaining Fair Deals for their Shareholders? PR Newswire
10.04.26 - PR Newswire
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? PR Newswire
08.04.26 - PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS PR Newswire
07.04.26 - PR Newswire
Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders?
Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders? PR Newswire
01.04.26 - PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) PR Newswire
01.04.26 wallstreetONLINE Redaktion
Fetter Pharma-Deal: Aktie explodiert +135 % nach Übernahme – Biogen zahlt brutal drauf und fällt
Biogen greift tief in die Tasche. Während die Aktie der übernommenen Firma dreistellig explodiert, verliert die eigene Aktie – Zweifel am Deal bleiben.Biogen greift tief in die Tasche. ...
31.03.26 - PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders PR Newswire
31.03.26 - PR Newswire
Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?
Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders? PR Newswire
27.01.26 - PR Newswire
TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 PR Newswire
18.07.24 - PR Newswire
Kuehn Law Encourages Investors of Apellis Pharmaceuticals, Inc. to Contact Law Firm
Kuehn Law Encourages Investors of Apellis Pharmaceuticals, Inc. to Contact Law Firm PR Newswire
14.12.23 - PR Newswire
Thinking about trading options or stock in Apellis Pharmaceuticals, Meta Platforms, NVIDIA, Micron Technology, or Gold Fields Limited?
Thinking about trading options or stock in Apellis Pharmaceuticals, Meta Platforms, NVIDIA, Micron Technology, or Gold Fields Limited? PR Newswire
06.10.23 - PR Newswire
Thinking about trading options or stock in NVIDIA, Tellurian, Albemarle Corporation, Apellis Pharmaceuticals, or Clearway Energy?
Thinking about trading options or stock in NVIDIA, Tellurian, Albemarle Corporation, Apellis Pharmaceuticals, or Clearway Energy? PR Newswire
29.09.23 - PR Newswire
APLS Investors Have Opportunity to Lead Apellis Pharmaceuticals, Inc. Securities Fraud Lawsuit
APLS Investors Have Opportunity to Lead Apellis Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire
28.09.23 - PR Newswire
APLS Investors Have Opportunity to Lead Apellis Pharmaceuticals, Inc. Securities Fraud Lawsuit
APLS Investors Have Opportunity to Lead Apellis Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire
27.09.23 - PR Newswire
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Apellis Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 2, 2023 - (NASDAQ: APLS)
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Apellis Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 2, 2023 - ...
26.09.23 - PR Newswire
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Apellis Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 2, 2023 - (NASDAQ: APLS)
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Apellis Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 2, 2023 - ...
24.09.23 - PR Newswire
APLS NOTICE: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 2 Deadline in Securities Class Action - APLS
APLS NOTICE: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 2 Deadline in ...
22.09.23 - PR Newswire
APELLIS PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Apellis Pharmaceuticals, Inc. - APLS
APELLIS PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action ...
22.09.23 - PR Newswire
APLS Investors Have Opportunity to Lead Apellis Pharmaceuticals, Inc. Securities Fraud Lawsuit
APLS Investors Have Opportunity to Lead Apellis Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire
21.09.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apellis Pharmaceuticals, Inc. - APLS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apellis Pharmaceuticals, Inc. - APLS PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »